Jane Street’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $108K | Sell |
44,268
-2,320
| -5% | -$5.68K | ﹤0.01% | 4956 |
|
|
2025
Q1 | $311K | Buy |
46,588
+6,214
| +15% | +$41.4K | ﹤0.01% | 4529 |
|
|
2024
Q4 | $508K | Sell |
40,374
-137,298
| -77% | -$1.73M | ﹤0.01% | 3943 |
|
|
2024
Q3 | $3.28M | Buy |
177,672
+47,134
| +36% | +$871K | ﹤0.01% | 1790 |
|
|
2024
Q2 | $2.81M | Buy |
+130,538
| New | +$2.81M | ﹤0.01% | 2332 |
|
|
2024
Q1 | – | Sell |
-48,048
| Closed | -$1.44M | – | 6234 |
|
|
2023
Q4 | $1.44M | Buy |
48,048
+12,353
| +35% | +$370K | ﹤0.01% | 2882 |
|
|
2023
Q3 | $731K | Sell |
35,695
-101,146
| -74% | -$2.07M | ﹤0.01% | 3208 |
|
|
2023
Q2 | $2.72M | Buy |
136,841
+112,289
| +457% | +$2.23M | ﹤0.01% | 2084 |
|
|
2023
Q1 | $421K | Buy |
24,552
+8,099
| +49% | +$139K | ﹤0.01% | 3852 |
|
|
2022
Q4 | $322K | Buy |
16,453
+5,107
| +45% | +$99.9K | ﹤0.01% | 3884 |
|
|
2022
Q3 | $181K | Sell |
11,346
-1,650
| -13% | -$26.3K | ﹤0.01% | 4640 |
|
|
2022
Q2 | $179K | Buy |
+12,996
| New | +$179K | ﹤0.01% | 4509 |
|
|
2022
Q1 | – | Sell |
-10,925
| Closed | -$239K | – | 6109 |
|
|
2021
Q4 | $239K | Buy |
10,925
+660
| +6% | +$14.4K | ﹤0.01% | 4244 |
|
|
2021
Q3 | $307K | Buy |
10,265
+5,377
| +110% | +$161K | ﹤0.01% | 3937 |
|
|
2021
Q2 | $216K | Sell |
4,888
-14,329
| -75% | -$633K | ﹤0.01% | 4354 |
|
|
2021
Q1 | $853K | Sell |
19,217
-1,518
| -7% | -$67.4K | ﹤0.01% | 2687 |
|
|
2020
Q4 | $1.14M | Buy |
20,735
+882
| +4% | +$48.4K | ﹤0.01% | 1972 |
|
|
2020
Q3 | $454K | Buy |
+19,853
| New | +$454K | ﹤0.01% | 2526 |
|